TCR2 Therapeutics Inc. - Price History
Stock symbol TCRR is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for TCRR (TCR2 Therapeutics Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| May 2024 | $1.48 | $1.48 |
| July 2023 | $1.48 | $1.48 |
| June 2023 | $1.48 | $1.48 |
| May 2023 | $1.48 | $1.48 |
| April 2023 | $1.76 | $1.76 |
| March 2023 | $1.50 | $1.50 |
| February 2023 | $1.25 | $1.25 |
| January 2023 | $1.45 | $1.45 |
| December 2022 | $1 | $1 |
| November 2022 | $1.33 | $1.33 |
| October 2022 | $1.57 | $1.57 |
| September 2022 | $1.80 | $1.80 |
| August 2022 | $2.72 | $2.72 |
| July 2022 | $3.18 | $3.18 |
| June 2022 | $2.90 | $2.90 |
| May 2022 | $2.32 | $2.32 |
| April 2022 | $2.13 | $2.13 |
| March 2022 | $2.76 | $2.76 |
| February 2022 | $2.71 | $2.71 |
| January 2022 | $3.34 | $3.34 |
| December 2021 | $4.66 | $4.66 |
| November 2021 | $5.15 | $5.15 |
| October 2021 | $6.30 | $6.30 |
| September 2021 | $8.51 | $8.51 |
| August 2021 | $16.77 | $16.77 |
| July 2021 | $12.44 | $12.44 |
| June 2021 | $16.41 | $16.41 |
| May 2021 | $19.15 | $19.15 |
| April 2021 | $22.71 | $22.71 |
| March 2021 | $22.08 | $22.08 |
| February 2021 | $26.46 | $26.46 |
| January 2021 | $25.73 | $25.73 |
| December 2020 | $30.93 | $30.93 |
| November 2020 | $27.24 | $27.24 |
| October 2020 | $19.67 | $19.67 |
| September 2020 | $20.32 | $20.32 |
| August 2020 | $20.22 | $20.22 |
| July 2020 | $16.75 | $16.75 |
| June 2020 | $15.36 | $15.36 |
| May 2020 | $10.10 | $10.10 |
| April 2020 | $9.54 | $9.54 |
| March 2020 | $7.74 | $7.74 |
| February 2020 | $11.88 | $11.88 |
| January 2020 | $14.68 | $14.68 |
| December 2019 | $14.28 | $14.28 |
| November 2019 | $16.95 | $16.95 |
| October 2019 | $12.43 | $12.43 |
| September 2019 | $15.03 | $15.03 |
| August 2019 | $16.86 | $16.86 |
| July 2019 | $15.54 | $15.54 |
| June 2019 | $14.31 | $14.31 |
| May 2019 | $15 | $15 |
| April 2019 | $16.63 | $16.63 |
| March 2019 | $17.43 | $17.43 |
| February 2019 | $21.41 | $21.41 |
TCRR
Price: $1.48
52 week price:
Earnings Per Share: -2.46 USD
P/E Ratio: -11.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 114400
Market Capitalization: 77.7 million